Cardio Diagnostics Holdings, Inc. CDIO NASDAQ

Cardio Diagnostics Holdings, Inc. (CDIO) reported total assets of $7.77M and total liabilities of $793.06K for fiscal year 2025, resulting in total equity of $6.97M.

The company held $5.11M in cash and short-term investments. Total debt stood at $695.62K, with net debt of $-4.42M. The Debt-to-Equity (D/E) ratio was 0.1 (conservative).

Current ratio is 9.79, indicating strong short-term liquidity. Interest coverage is -438.1x (weak).

Criteria supported by this page:

• HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (0/100) — Total assets $7.77M and equity $6.97M support the company's competitive scale
• VALUE (100/100) — Debt-to-Equity 0.1 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 48/100 with 2/7 criteria passed.

ATNF

180 Life Sciences Corp.

$7.04

-7.49%

VECT

VectivBio Holding AG

$16.87

+0.12%

IMMX

Immix Biopharma, Inc.

$10.04

+1.93%

ZURA

Zura Bio Limited

$5.69

-0.52%

PYXS

Pyxis Oncology, Inc.

$1.71

+0.59%

ELEV

Elevation Oncology, Inc.

$0.37

-2.12%

PHIO

Phio Pharmaceuticals Corp.

$1.32

+2.33%

SONN

Sonnet BioTherapeutics Holdings, Inc.

$1.26

-59.35%